XML 68 R52.htm IDEA: XBRL DOCUMENT v3.25.1
Share-based payment (Tables)
12 Months Ended
Dec. 31, 2024
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Schedule of Valuation Models and Main Assumptions

To determine the fair value of share-based payments related to the 2004 Option plan, management used the following valuation models and main assumptions:

 

December 31,
2023

 

 

December 31,
2022

 

Discounted cash flow - DCF: (3)

 

 

 

 

 

 

Discount rate(2)

 

 

12.50

%

 

 

15.30

%

Expected perpetuity growth

 

 

3.72

%

 

 

3.98

%

Option pricing model – OPM:

 

 

 

 

 

 

Discount rate(2)

 

 

3.00

%

 

 

7.00

%

Volatility mainly(1)

 

 

30.52

%

 

 

38.05

%

Binomial tree:

 

 

 

 

 

 

Discount rate(2)

 

 

3.00

%

 

 

7.00

%

Volatility mainly(1)

 

 

36.1

%

 

 

39.97

%

 

(1)
The expected volatility is based on the historic volatility of comparable entities within the industry, with a period of time equivalent to the estimated contractual life of the share options granted by the Company.
(2)
The risk-free interest rates that were considered within the discount rates for the years 2023 and 2022 were 3.96% and 3.45%, respectively, which corresponded to the interpolated U.S. Constant Maturity Treasury yield as of the valuation date.
(3)
Given the Company has now an observable market price for its share price, the discounted cash flow model was no longer required.

To determine the fair value of share-based payments related to the Equity Incentive Plan, management used the Binomial tree valuation model and the following assumptions:

 

 

For the year ended

 

December 31, 2024

Expected life of the share option or appreciation right

 

10- years (*)

Volatility of the stock price of comparable companies

 

37.21% (*)

*Same base as explained above to determine the fair value of the 2004 Option plan

Summary of Outstanding Share Options, Strike Prices and Expiry Dates

The tables below set forth the number of Class C common shares issuable upon the exercise of Common Options and Exit Options granted per year (net of forfeitures) and the weighted average strike prices of the Class C common

shares subject to Common Options and Exit Options (considering the 3-for-1 share split effected in connection with the IPO).

 

 

Number of Common Options

 

 

2024

 

 

2023

 

 

2022

 

Outstanding as of January 1st

 

 

34,991,250

 

 

 

 

29,366,250

 

 

 

 

22,031,250

 

Granted during the year

 

 

 

 

 

 

6,270,000

 

 

 

 

7,335,000

 

Forfeited during the year

 

 

(1,492,500

)

 

 

 

(645,000

)

 

 

 

 

Outstanding as of December 31st

 

 

33,498,750

 

 

 

 

34,991,250

 

 

 

 

29,366,250

 

Exercisable as of December 31st

 

 

 

 

 

 

 

 

 

 

 

Weighted average strike price

US$

 

5.98

 

 

US$

 

6.02

 

 

US$

 

4.69

 

The following table illustrates the outstanding share options under the 2004 Option plan and the corresponding strike prices (considering the 3-for-1 share split effected in connection with the IPO) and the expiry dates:

Grant Date
December of

 

Number of outstanding
options granted – December 31

 

 

Strike Price
US Dollars

 

 

Average
option
fair value
at grant
date
(1)

 

 

Average
fair value
of share
at grant
date

 

 

Expiry Date,
December of

 

 

2024

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

2006

 

 

600,000

 

 

 

600,000

 

 

 

600,000

 

 

$

0.50

 

 

N/A

 

 

N/A

 

 

2036

2006

 

 

472,500

 

 

 

472,500

 

 

 

472,500

 

 

$

0.33

 

 

N/A

 

 

N/A

 

 

2036

2007

 

 

465,000

 

 

 

465,000

 

 

 

465,000

 

 

$

0.58

 

 

N/A

 

 

N/A

 

 

2037

2008

 

 

810,000

 

 

 

810,000

 

 

 

810,000

 

 

$

0.83

 

 

N/A

 

 

N/A

 

 

2038

2009

 

 

900,000

 

 

 

900,000

 

 

 

900,000

 

 

$

1.08

 

 

N/A

 

 

N/A

 

 

2039

2010

 

 

1,020,000

 

 

 

1,080,000

 

 

 

1,080,000

 

 

$

1.08

 

 

N/A

 

 

N/A

 

 

2040

2011

 

 

1,252,500

 

 

 

1,312,500

 

 

 

1,312,500

 

 

$

1.33

 

 

N/A

 

 

N/A

 

 

2041

2012

 

 

1,252,500

 

 

 

1,312,500

 

 

 

1,312,500

 

 

$

1.67

 

 

N/A

 

 

N/A

 

 

2042

2013

 

 

1,323,750

 

 

 

1,402,500

 

 

 

1,402,500

 

 

$

2.00

 

 

N/A

 

 

N/A

 

 

2043

2014

 

 

1,406,250

 

 

 

1,481,250

 

 

 

1,481,250

 

 

$

2.17

 

 

$

0.01

 

 

$

0.03

 

 

2044

2015

 

 

1,458,000

 

 

 

1,548,000

 

 

 

1,548,000

 

 

$

2.17

 

 

$

0.02

 

 

$

0.04

 

 

2045

2016

 

 

1,733,250

 

 

 

1,823,250

 

 

 

1,823,250

 

 

$

1.90

 

 

$

0.000030

 

 

$

0.000030

 

 

2046

2017

 

 

720,000

 

 

 

821,250

 

 

 

851,250

 

 

$

2.72

 

 

$

0.0002

 

 

$

0.0010

 

 

2047

2018

 

 

813,750

 

 

 

907,500

 

 

 

945,000

 

 

$

3.10

 

 

$

0.13

 

 

$

0.36

 

 

2048

2019

 

 

780,000

 

 

 

847,500

 

 

 

892,500

 

 

$

4.33

 

 

$

0.41

 

 

$

1.01

 

 

2049

2020

 

 

963,750

 

 

 

1,042,500

 

 

 

1,095,000

 

 

$

5.00

 

 

$

2.50

 

 

$

4.48

 

 

2050

2021

 

 

4,830,000

 

 

 

4,935,000

 

 

 

5,040,000

 

 

$

6.33

 

 

$

3.75

 

 

$

6.54

 

 

2051

2022

 

 

6,727,500

 

 

 

6,960,000

 

 

 

7,335,000

 

 

$

9.67

 

 

$

2.08

 

 

$

4.18

 

 

2052

2023

 

 

5,970,000

 

 

 

6,270,000

 

 

 

 

 

$

12.17

 

 

$

9.37

 

 

$

15.40

 

 

2053

 

 

33,498,750

 

 

 

34,991,250

 

 

 

29,366,250

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) The Company applied the exemption permitted by IFRS 1, First-time Adoption of IFRS, for share-based payments that were vested before the transition date and only applied IFRS 2 for the options granted in 2014 onwards. Therefore, the fair value of options granted from 2006 to 2013 has not been calculated nor recognized.

Restricted Stock Units  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Summary of Outstanding Share Options, Strike Prices and Expiry Dates

 

Number of restricted stock units (2)

 

Outstanding as of January 1, 2024

 

 

 

Granted during the year

 

 

585,000

 

Forfeited during the year

 

 

 

Outstanding as of December 31, 2024

 

 

585,000

 

Exercisable as of December 31, 2024

 

 

 

(2)
Each Restricted Stock Unit (RSUs) is equal to one Class A common share. 305,000 RSUs were granted to senior management and certain Board members as a compensation bonus, 280,000 were granted to senior management as long-term incentives, and 20,000 RSUs were approved to compensate certain senior advisors, but they are not yet granted. The 305,000 RSUs are subject to a cliff-vesting over a one-year period, with
100% of the total RSUs vesting in a single installment on January 1, 2026. The 280,000 RSUs vest over three years, with 33.33% of the RSUs vesting at the end of the first, second and third anniversary of the Grant Date. The 20,000 RSUs will be subject to a cliff-vesting over a one-year period, with 100% of the RSUs vesting in a single installment on the first anniversary of the respective grant date.
Exit options  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Summary of Outstanding Share Options, Strike Prices and Expiry Dates

 

 

Number of Exit Options

 

2024

 

 

2023

 

 

2022

 

Outstanding as of January 1st

 

 

7,444,974

 

 

 

 

7,064,982

 

 

 

 

7,064,982

 

Granted during the year

 

 

 

 

 

 

379,992

 

 

 

 

 

Forfeited during the year

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of December 31st

 

 

7,444,974

 

 

 

 

7,444,974

 

 

 

 

7,064,982

 

Exercisable as of December 31st

 

 

 

 

 

 

 

 

 

 

 

Weighted average strike price

US$

 

3.43

 

 

US$

 

3.43

 

 

US$

 

3.45

 

The following table illustrates the outstanding Exit options under the 2004 Option plan and the corresponding strike prices (considering the 3-for-1 share split effected in connection with the IPO) and the expiry dates:

 

Grant Date
December of

 

Number of outstanding
options granted – December 31

 

 

Strike Price
US Dollars

 

 

Fair value at grant date (1)

 

 

Expiry Date,
December of

 

 

2024

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

 

2020

 

 

3,034,992

 

 

 

3,034,992

 

 

 

3,034,992

 

 

$

2.37

 

 

$

3.04

 

 

2050

2020

 

 

3,129,990

 

 

 

3,129,990

 

 

 

3,129,990

 

 

$

3.67

 

 

$

2.77

 

 

2050

2021

 

 

900,000

 

 

 

900,000

 

 

 

900,000

 

 

$

6.33

 

 

$

3.84

 

 

2051

2023

 

 

189,996

 

 

 

189,996

 

 

 

 

 

$

2.37

 

 

$

2.68

 

 

2051

2023

 

 

189,996

 

 

 

189,996

 

 

 

 

 

$

3.67

 

 

$

2.53

 

 

2051

 

 

7,444,974

 

 

 

7,444,974

 

 

 

7,064,982

 

 

 

 

 

 

 

 

 

 

(1) Due to the change in the estimated date of the IPO, the fair value of the options was recalculated. Previously, the fair values of the options were US$3.02 (strike price US$2.37) and US$2.76 (strike price US$3.67) for the 2020 grant, and US$3.82 (strike price US$6.33) for the 2021 grant.

Equity Incentive Plan  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Summary of Outstanding Share Options, Strike Prices and Expiry Dates

On December 10, 2024, the Company’s Board of directors approved the following awards under the new Equity Incentive Plan:

 

Number of stock options (1)

 

Outstanding as of January 1, 2024

 

 

1,310,000

 

Granted during the year

 

 

 

Forfeited during the year

 

 

 

Outstanding as of December 31, 2024

 

 

1,310,000

 

Exercisable as of December 31, 2024

 

 

 

Weighted average strike price

US$

 

29.09

 

(1)
A pool of 1,320,000 stock options, each exercisable for one Class A common share, to the Company’s Senior Leadership, of which 1,310,000 have been granted. These stock options vest over four years, with 25.0% vesting at the end of each of the first, second, third and fourth anniversary of December 10, 2024 (the “Grant Date”). The exercise price was US$29.09 per share, the closing price of the Class A common share on the Grant Date.
Equity Incentive Options  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Summary of Outstanding Share Options, Strike Prices and Expiry Dates

The following table illustrates the outstanding equity incentive options under the 2024 Equity Incentive Plan and the corresponding strike price and expiry date:

Grant date
December of

 

Number of outstanding
Options granted – December 31
2024

 

 

Strike price
US Dollars

 

 

Fair value at grant date

 

 

Expiry date,
December of

2024

 

 

1,310,000

 

 

$

29.09

 

 

$

13.92

 

 

2034

 

 

1,310,000